Sort   by:  
 Page size 
UnknownThe immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis.
Not available
S-EPMC3465432 | biostudies-literature
UnknownA plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.
Not available
S-EPMC6662820 | biostudies-literature
UnknownFunctional rare and low frequency variants in BLK and BANK1 contribute to human lupus.
Not available
S-EPMC6525203 | biostudies-literature
UnknownP2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance.
Not available
S-EPMC8669517 | biostudies-literature
UnknownDominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.
Not available
S-EPMC5903850 | biostudies-literature
UnknownDeletions in VANGL1 are a risk factor for antibody-mediated kidney disease.
Not available
S-EPMC8714939 | biostudies-literature
UnknownDimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10831058 | biostudies-literature
UnknownGWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
Sort   by:  
 Page size